Cargando…
Treatment of invasive candidiasis with caspofungin in the intensive care unit
Autores principales: | DiNubile, MJ, Lupinacci, RJ, Sable, CA, Kartsonis, NA |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3301577/ http://dx.doi.org/10.1186/cc2021 |
Ejemplares similares
-
1955. A Randomized, Double-Blind Study to Evaluate the Safety, Tolerability, and Efficacy of Caspofungin vs. Amphotericin B Deoxycholate in the Treatment of Invasive Candidiasis in Neonates and Infants ≤3 Months of Age
por: Kim, Jason, et al.
Publicado: (2018) -
A double-blind comparative study of the safety and efficacy of caspofungin versus micafungin in the treatment of candidiasis and aspergillosis
por: Kohno, S., et al.
Publicado: (2012) -
Treatment and prophylaxis of invasive candidiasis with anidulafungin, caspofungin and micafungin - review of the literature
por: Glöckner, A
Publicado: (2011) -
Evaluation of thrombocytopenia in a general intensive care unit
por: Youssef, NCM, et al.
Publicado: (2001) -
Appropriateness of antibiotic use and its influence on outcome of patients admitted to an intensive care unit
por: Silva, NB, et al.
Publicado: (2001)